FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bo Skaaning Jensen

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Patch-Clamp Techniques

Concepts & Ideas

Living Beings

Rats

Physiology

Co-author Network

Publications

TOP 3
Leif Panduro Jensen; M Lepäntalo; J E Fossdal; OC Røder; Bo Skaaning Jensen; M S Madsen; O Grenager; H Fasting; H O Myhre; Niels Baekgaard; OM Nielsen; U Helgstrand; Torben V Schroeder
Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study.
Raj Kumar Pandita; Lars Christian B Rønn; Bo Skaaning Jensen; Karl-Erik Andersson
Urodynamic effects of intravesical administration of the new small/intermediate conductance calcium activated potassium channel activator NS309 in freely moving, conscious rats.
Paola Pedarzani; Jaime E McCutcheon; Gregor Rogge; Bo Skaaning Jensen; palle christophersen; Charlotte Hougaard; Dorte Strøbaek; Martin Stocker
Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bo Skaaning Jensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Leif Panduro Jensen; M Lepäntalo; J E Fossdal; OC Røder; Bo Skaaning Jensen; M S Madsen; O Grenager; H Fasting; H O Myhre; Niels Baekgaard; OM Nielsen; U Helgstrand; Torben V Schroeder
Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2007;34(1):44-9.
2006: Raj Kumar Pandita; Lars Christian B Rønn; Bo Skaaning Jensen; Karl-Erik Andersson
Urodynamic effects of intravesical administration of the new small/intermediate conductance calcium activated potassium channel activator NS309 in freely moving, conscious rats.
The Journal of urology 2006;176(3):1220-4.
2005: Paola Pedarzani; Jaime E McCutcheon; Gregor Rogge; Bo Skaaning Jensen; palle christophersen; Charlotte Hougaard; Dorte Strøbaek; Martin Stocker
Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons.
The Journal of biological chemistry 2005;280(50):41404-11.
2005: Henrik Sindal Jensen; Kirstine Callø; Thomas Jespersen; Bo Skaaning Jensen; Søren-Peter Olesen
The KCNQ5 potassium channel from mouse: a broadly expressed M-current like potassium channel modulated by zinc, pH, and volume changes.
Brain research. Molecular brain research 2005;139(1):52-62.
2005: Jon Bondebjerg; Henrik Fuglsang; Kirsten Rosendal Valeur; Dorte Wissing Kaznelson; Johnny Arnsdorf Hansen; René Orup Pedersen; Berit Olsen Krogh; Bo Skaaning Jensen; Conni Lauritzen; Gitte Petersen; John Pedersen; Lars Naerum
Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI).
Bioorganic & medicinal chemistry 2005;13(14):4408-24.
2004: Hanne B Rasmussen; Morten Møller; Hans-Günther Knaus; Bo Skaaning Jensen; Søren-Peter Olesen; Nanna K Jørgensen
Subcellular localization of the delayed rectifier K(+) channels KCNQ1 and ERG1 in the rat heart.
American journal of physiology. Heart and circulatory physiology 2004;286(4):H1300-9.
2003: Trine Ljungstrom; Morten Grunnet; Bo Skaaning Jensen; Søren-Peter Olesen
Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels.
Pflügers Archiv : European journal of physiology 2003;446(6):684-94.
2003: Gordon Blackburn-Munro; Bo Skaaning Jensen
The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain.
European journal of pharmacology 2003;460(2-3):109-16.
2003: E Yus-Nájera; A Muñoz; N Salvador; Bo Skaaning Jensen; Hanne B Rasmussen; J Defelipe; A Villarroel
Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation.
Neuroscience 2003;120(2):353-64.
2003: Niels J Willumsen; Morten Bech; Søren-Peter Olesen; Bo Skaaning Jensen; Mads P G Korsgaard; palle christophersen
High throughput electrophysiology: new perspectives for ion channel drug discovery.
Receptors & channels 2003;9(1):3-12.
2002: Bo Skaaning Jensen; M Hertz; palle christophersen; Lars Siim Madsen
The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.
Expert opinion on therapeutic targets 2002;6(6):623-36.
2002: Delphine S Dupuis; Rikke Louise Schrøder; Thomas Jespersen; Jeppe K Christensen; palle christophersen; Bo Skaaning Jensen; Søren-Peter Olesen
Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352.
European journal of pharmacology 2002;437(3):129-37.
2002: Bo Skaaning Jensen
BMS-204352: a potassium channel opener developed for the treatment of stroke.
CNS drug reviews 2002;8(4):353-60.
2001: Bo Skaaning Jensen; Dorte Strøbaek; Søren-Peter Olesen; palle christophersen
The Ca2+-activated K+ channel of intermediate conductance: a molecular target for novel treatments?
Current drug targets 2001;2(4):401-22.
2001: Rikke Louise Schrøder; Thomas Jespersen; palle christophersen; Dorte Strøbaek; Bo Skaaning Jensen; Søren-Peter Olesen
KCNQ4 channel activation by BMS-204352 and retigabine.
Neuropharmacology 2001;40(7):888-98.
2001: Morten Grunnet; Thomas Jespersen; Kamilla Angelo; Christian Frøkjaer-Jensen; Dan A Klaerke; Søren-Peter Olesen; Bo Skaaning Jensen
Pharmacological modulation of SK3 channels.
Neuropharmacology 2001;40(7):879-87.
2001: R Søgaard; Trine Ljungstrøm; KA Pedersen; Søren-Peter Olesen; Bo Skaaning Jensen
KCNQ4 channels expressed in mammalian cells: functional characteristics and pharmacology.
American journal of physiology. Cell physiology 2001;280(4):C859-66.
2001: Yuliya V Korolkova; Sergey A Kozlov; Aleksey V Lipkin; Kirill A Pluzhnikov; J K Hadley; A K Filippov; D A Brown; Kamilla Angelo; Dorte Strøbaek; Thomas Jespersen; Søren-Peter Olesen; Bo Skaaning Jensen; Eugene V Grishin
An ERG channel inhibitor from the scorpion Buthus eupeus.
The Journal of biological chemistry 2001;276(13):9868-76.
2001: Morten Grunnet; Bo Skaaning Jensen; Søren-Peter Olesen; Dan A Klaerke
Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels.
Pflügers Archiv : European journal of physiology 2001;441(4):544-50.
2000: Rikke Louise Schrøder; Bo Skaaning Jensen; Dorte Strøbaek; Søren-Peter Olesen; palle christophersen
Activation of the human, intermediate-conductance, Ca2+-activated K+ channel by methylxanthines.
Pflügers Archiv : European journal of physiology 2000;440(6):809-18.
2000: KA Pedersen; Nanna K Jørgensen; Bo Skaaning Jensen; Søren-Peter Olesen
Inhibition of the human intermediate-conductance, Ca2+-activated K+ channel by intracellular acidification.
Pflügers Archiv : European journal of physiology 2000;440(1):153-6.
1999: Bo Skaaning Jensen; N Odum; Nanna K Jorgensen; palle christophersen; Søren-Peter Olesen
Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(19):10917-21.
1999: Tino Dyhring; Bo Skaaning Jensen; Dorte Strøbaek; palle christophersen; Søren-Peter Olesen; Philip K Ahring
Functional characterization of a cloned human intermediate-conductance Ca(2+)-activated K+ channel.
Annals of the New York Academy of Sciences 1999;868():423-6.
1998: Bo Skaaning Jensen; D Strobaek; palle christophersen; Tino Dyhring; C Hansen; A Silahtaroglu; Søren-Peter Olesen; Philip K Ahring
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.
The American journal of physiology 1998;275(3 Pt 1):C848-56.
1998: Thure Krarup; Lene Jakobsen; Bo Skaaning Jensen; Else Hoffmann
Na+-K+-2Cl- cotransport in Ehrlich cells: regulation by protein phosphatases and kinases.
The American journal of physiology 1998;275(1 Pt 1):C239-50.
1997: Bo Skaaning Jensen; Else Hoffmann
Hypertonicity enhances expression of functional Na+/K+/2Cl- cotransporters in Ehrlich ascites tumour cells.
Biochimica et biophysica acta 1997;1329(1):1-6.
1996: T Krarup; Bo Skaaning Jensen; Else Hoffmann
Occlusion of K+ in the Na+/K+/2Cl- cotransporter of Ehrlich ascites tumor cells.
Biochimica et biophysica acta 1996;1284(1):97-108.
1994: A K Larsen; Bo Skaaning Jensen; Else Hoffmann
Activation of protein kinase C during cell volume regulation in Ehrlich mouse ascites tumor cells.
Biochimica et biophysica acta 1994;1222(3):477-82.
1993: Bo Skaaning Jensen; F Jessen; Else Hoffmann
Na+, K+, Cl- cotransport and its regulation in Ehrlich ascites tumor cells. Ca2+/calmodulin and protein kinase C dependent pathways.
The Journal of membrane biology 1993;131(3):161-78.